Cutaneous manifestations of chronic kidney disease

Clinics in Dermatology

Volumn 26, Issue 3, 2008, Pages 255-264

  Kurban, Mazen S ^a   Boueiz, Adel ^a   Kibbi, Abdul Ghani ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPHA INTERFERON; ANTIHISTAMINIC AGENT; CAPSAICIN; CHARCOAL; COLESTYRAMINE; DEFEROXAMINE; FUROSEMIDE; GABAPENTIN; HEPARIN; ISOTRETINOIN; LIDOCAINE; METHOTREXATE; MEXILETINE; NALIDIXIC ACID; NALOXONE; NALTREXONE; NICERGOLINE; ONDANSETRON; OPIATE ANTAGONIST; PLACEBO; PRIMROSE OIL; RECOMBINANT ERYTHROPOIETIN; RETINOID; STEROID; TETRACYCLINE; THALIDOMIDE; TRIAMCINOLONE; UNINDEXED DRUG; VASODILATOR AGENT;

ABSENCE OF SIDE EFFECTS; ACIDOSIS; ACQUIRED PERFORATING DERMATOSIS; ACUPUNCTURE; BULLOUS SKIN DISEASE; CALCINOSIS; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; CLINICAL TRIAL; DIET THERAPY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DIZZINESS; DRUG EFFICACY; DRUG HALF LIFE; FATIGUE; GASTROINTESTINAL DISEASE; HEMODIALYSIS; HUMAN; HYPERBARIC OXYGEN; KIDNEY TRANSPLANTATION; NAIL DYSTROPHY; NEPHROGENIC FIBROSING DERMOPATHY; OBSTRUCTIVE JAUNDICE; PATHOGENESIS; PHOTOTHERAPY; POLYCYTHEMIA VERA; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; PRURITUS; PSEUDOPORPHYRIA; PUVA; REVIEW; RISK FACTOR; SAUNA; SKIN BIOPSY; SKIN MANIFESTATION; SOMNOLENCE; ULTRAVIOLET B RADIATION; UNSPECIFIED SIDE EFFECT; UREMIA; VESICULAR RASH;

FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; SKIN DISEASES;

EID: 47149087916     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2007.10.017     Document Type: Review

References (82)

1. Bencini P.L., Montagnino G., Citterio A., Graziani G., Crosti C., and Ponticelli C. Cutaneous abnormalities in uremic patients. Nephron 40 (1985) 316-321
2. Stahle-Backdahl M. Uremic pruritus: clinical and experimental studies. Acta Derm Venereol (Stockh) 145 (1989) 1-38
3. Gilchrest B.A., Stern R.S., et al. Clinical features of pruritus among patients undergoing maintenance hemodialysis. Arch Dermatol 118 (1982) 154-157
4. Hampers C.L., Katz A.I., et al. Disappearance of uremic itching after subtotal parathyroidectomy. N Engl J Med 279 (1968) 695-697
5. Chou F.F. A study on pruritus after parathyroidectomy for secondary hyperparathyroidism. J Am Coll Surg 190 (2000) 65-70
6. Stahle-Backdahl M. Uremic pruritus. Semin Dermatol 14 (1995) 297-301
7. Kato A. Pruritus and hydration state of stratum corneum in hemodialysis patients. Am J Nephrol 20 (2000) 437-442
8. Vanholder R., and Smet R.D. Pathophysiologic effects of uremic retention solutes. J Am Soc Nephrol 10 (1999) 1815-1823
9. Zakrzewska-Pniewska B., and Jedras M. Is pruritus in chronic uremic patients related to peripheral somatic and autonomic neuropathy?. Neurophysiol Clin 31 (2001) 181-193
10. Mettang T., Pauli-Magnus C., and Alscher D.M. Uraemic pruritus-new perspectives and insights from recent trials. Nephrol Dial Transplant 17 (2002) 1558-1563
11. Garssen J., Vandebriel R.J., et al. UVB exposure-induced systemic modulation of Th1- and Th2-mediated immune responses. Immunology 97 (1999) 506-514
12. Andersen L.W., Friedberg M., and Lokkegaard N. Naloxone in treatment of uremic pruritus: a case history. Clin Nephrol 21 (1984) 355-356
13. Peer G., Kivity S., et al. Randomized crossover trial of naltrexone in uraemic pruritus. Lancet 348 (1996) 1552-1554
14. Breneman D.L., Cardone J.S., et al. Topical capsaicin for the treatment of hemodialysis-related pruritus. J Am Acad Dermatol 26 (1992) 91-94
15. Pauli-Magnus C., Klumpp S., et al. Short-term efficacy of tacrolimus ointment in severe uremic pruritus. Perit Dial Int 6 (2000) 802-803
16. Peck L.W., Monsen E.R., and Ahmed S. Effect of three sources of long-chain fatty acids on the plasma fatty acid profile, plasma prostaglandin E2 concentration and pruritus symptoms in hemodialysis patients. Am J Clin Nutr 64 (1996) 210-214
17. Yoshimoto-Furuie K., Yoshimoto K., et al. Effects of oral supplementation with evening primrose oil for six weeks on plasma essential fatty acids and uremic skin symptoms in hemodialysis patients. Nephron 81 (1999) 151-159
18. Hiroshige K., Kabashima N., et al. Optimal dialysis improves uremic pruritus. Am J Kidney Dis 25 (1995) 413-419
19. Gilchrest B.A., Rowe J.W., et al. Ultraviolet phototherapy of uremic pruritus: long-term results and possible mechanisms of action. Ann Intern Med 91 (1979) 17-21
20. Fjellner B. Experimental and clinical pruritus. Acta Derm Venereol (Stockh) 97 (1981) 1-34
21. Shapiro R., and Stockard H. Successful treatment of uremic pruritus: the acupuncture approach revisited. Dial Transplant 32 (2003) 257-265
22. Taipa L., Cheigh J.S., and David D.S. Pruritus in dialysis patients treated with parenteral lidocaine. N Engl J Med 296 (1977) 261
23. Schwartz I.F., and Iaina A. Uraemic pruritus. Nephrol Dial Transplant 14 (1999) 834-839
24. Silverberg D.S., Iaina A., et al. Cholestyramine in uremic pruritus. BMJ 1 (1977) 752-753
25. Yatzidis H., Digenis P., and Tountas C. Heparin treatment in uremic itching. JAMA 222 (1972) 1183-1184
26. De Marchi S., Cecchin E., et al. Relief of pruritus and decreases in plasma histamine concentration during erythropoietin therapy in patients with uremia. N Engl J Med 326 (1992) 969-974
27. Balaskas E.V., Bamihas G.I., et al. Histamine and serotonin in uremic pruritus: effect of ondansetron in CAPD-pruritic patients. Nephron 78 (1998) 395-402
28. Bousquet J., Rivory J.P., et al. Double-blind, placebo-controlled study of nicergoline in the treatment of pruritus in patients receiving maintenance hemodialysis. J Allergy Clin Immunol 83 (1989) 825-828
29. Gunal A.I., Ozalp G., et al. Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial. Nephrol Dial Transplant 19 (2004) 3137-3139
30. Rosner M.H. Cromolyn sodium: a potential therapy for uremic pruritus?. Hemodial Int 10 (2006) 189-192
31. Farrell A.M. Acquired perforating dermatosis in renal and diabetic patients. Lancet (1997) 349
32. Pedragosa R., Knobel H.J., et al. Reactive perforating collagenosis in Hodgkin's disease. Am J Dermatopathol 9 (1987) 41-44
33. Morton C.A., Henderson I.S., et al. Acquired perforating dermatosis in a British dialysis population. Br J Dermatol 135 (1996) 671-677
34. Hood A., Hardegen G.L., et al. Kyrle's disease in patients with chronic renal failure. Arch Dermatol 118 (1982) 85-88
35. Patterson J.W., and Brown P.C. Ultrastructural changes in acquired perforating dermatosis. Int J Dermatol 31 (1992) 201-205
36. Zelger B., Hintner H., et al. Acquired perforating dermatosis: transepidermal elimination of DNA material and possible role of leukocytes in pathogenesis. Arch Dermatol 127 (1991) 695-700
37. Haftek M., Euvrard S., et al. Acquired perforating dermatosis of diabetes mellitus and renal failure: further ultrastructural clues to its pathogenesis. J Cutan Pathol (1993) 330-335
38. Blanchley J.D., Blankenship M., et al. Uraemic pruritus: skin divalent ion content and response to ultraviolet therapy. Am J Kidney Dis 5 (1985) 237-241
39. Morgan M.B., Truitt C.A., et al. Fibronectin and the extracellular matrix in the perforating disorders of the skin. Am J Dermatopathol 20 (1998) 147-154
40. Saldanha L.F., Gonick H.C., et al. Silicon-related syndrome in dialysis patients. Nephron 77 (1997) 48-56
41. Hudson J.B., and Dennis Jr. A.J. Transverse white lines in the fingernails after acute and chronic renal failure. Arch Intern Med 117 (1966) 276-279
42. Seavolt M.B., Sarro R.A., Levin K., and Camisa C. Mees' lines in a patient following acute arsenic intoxication. Int J Dermatol 41 (2002) 399-401
43. Leyden J.J., and Wood M.G. The "half-and-half nail": a uremic onychopathy. Arch Dermatol 105 (1972) 591-592
44. Tercedor J., Lopez Hernandez B., and Manuel Rodenas J. Nail diseases in haemodialysis patients: case-control study. Br J Dermatol 144 (2001) 445-446
45. Lindsay P.G. The half-and-half nail. Arch Intern Med 119 (1967) 583-587
46. Lubach D., Strubbe J., and Schmidt J. The 'half and half nail' phenomenon in chronic hemodialysis patients. Dermatologica 164 (1982) 350-353
47. Stewart W.K., and Raffle E.J. Brown nail-bed arcs and chronic renal disease. Br Med J 1 (1972) 784-786
48. Saray Y., Seckin D., Gulec A.T., Akgun S., and Haberal M. Nail disorders in hemodialysis patients and renal transplant recipients: a case-control study. J Am Acad Dermatol 50 (2004) 197-202
49. Poh-Fitzpatrick M.B., Masullo A.S., and Grossman M.E. Porphyria cutanea tarda associated with chronic renal disease and hemodialysis. Arch Dermatol 116 (1980) 191-195
50. Glynne P., Deacon A., Goldsmith D., Pusey C., and Clutterbuck E. Bullous dermatoses in end-stage renal failure: porphyria or pseudoporphyria?. Am J Kidney Dis 34 (1999) 155-160
51. Mamet R., Gafter U., Korzets A., and Schoenfeld N. Decreased uroporphyrinogen decarboxylase activity in patients with end-stage renal disease undergoing hemodialysis. Nephron 70 (1995) 202-206
52. Albalate M., Farinas M.C., Octavio J.G., Perez J.H., Goicoechea M., and Caramelo C. Development of porphyria cutanea tarda in a hemodialysis patient after reactivation of hepatitis C virus infection. Nephron 88 (2001) 170-173
53. Topi G.C., Alessandro G.L., Cancarini G.C., De Costanza F., Griso D., and Ravelli M. Porphyria cutanea tarda in a haemodialysed patient. Br J Dermatol 104 (1981) 579-580
54. Keczkes K., and Farr M. Bullous dermatosis of chronic renal failure. Br J Dermatol 95 (1976) 541-546
55. Harber L.C., and Bickers D.R. Porphyria and pseudoporphyria. J Invest Dermatol 82 (1984) 207-209
56. Stevens B.R., Fleischer Jr. A.B., Piering F., and Crosby D.L. Porphyria cutanea tarda in the setting of renal failure. Response to renal transplantation. Arch Dermatol. 129 (1993) 337-339
57. Vadoud-Seyedi J., de Dobbeleer G., and Simonart T. Treatment of haemodialysis-associated pseudoporphyria with N-acetylcysteine: report of two cases. Br J Dermatol 142 (2000) 580-581
58. Khan I.U., Bhol K.C., and Ahmed A.R. Linear IgA bullous dermatosis in a patient with chronic renal failure: response to intravenous immunoglobulin therapy. J Am Acad Dermatol 40 (1999) 485-488
59. Serwin A.B., Mysliwiec H., Laudanska H., and Chodynicka B. Linear IgA bullous dermatosis in a diabetic patient with chronic renal failure. Int J Dermatol 41 (2002) 778-780
60. Mazhar A.R., Johnson R.J., et al. Risk factors and mortality associated with calciphylaxis in end-stage renal disease. Kidney Int 60 (2001) 324-332
61. Shearer M.J. Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification. Curr Opin Clin Nutr Metab Care 3 (2000) 433-438
62. Zacharias J.M., Fontaine B., and Fine A. Calcium use increases risk of calciphylaxis: a case-control study. Perit Dial Int 19 (1999) 248-252
63. Mori K., Shioi A., et al. Dexamethasone enhances in vitro vascular calcification by promoting osteoblastic differentiation of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 19 (1999) 2112-2118
64. Coates T., Kirkland G.S., et al. Cutaneous necrosis from calcific uremic arteriolopathy. Am J Kidney Dis 32 (1998) 384-391
65. Janigan D.T., Hirsch D.J., et al. Calcified subcutaneous arterioles with infarcts of the subcutis and skin ("calciphylaxis") in chronic renal failure. Am J Kidney Dis 35 (2000) 588-597
66. Llach F. The evolving pattern of calciphylaxis: therapeutic considerations. Nephrol Dial Transplant 16 (2001) 448-451
67. Dwyer K.M., Francis D.M.A., et al. Calcific uraemic arteriolopathy: local treatment and hyperbaric oxygen therapy. Nephrol Dial Transplant 17 (2002) 1148-1149
68. Auron A., Shao L., and Warady B.A. Nephrogenic fibrosing dermopathy in children. Pediatr Nephrol (2006) [electronic publication ahead of print]
69. Streams B.N., Vincent V., Liégeois N., and Moschella S.M. Clinical and pathologic features of nephrogenic fibrosing dermopathy: a report of two cases. J Am Acad Dermatol 48 (2003) 42-47
70. Gilliet M., Cozzio A., Burg G., and Nestle F.O. Successful treatment of three cases of nephrogenic fibrosing dermopathy with extracorporeal photopheresis. Br J Dermatol 152 (2005) 531-536
71. Ruiz-Genao D.P., Pascual-Lopez M.P., Fraga S., Aragues M., and Garcia-Diez A. Osseous metaplasia in the setting of nephrogenic fibrosing dermopathy. J Cutan Pathol 32 (2005) 172-175
72. Glaich A.S., Martinelli P.T., Markus R.F., and Hsu S. Generalized elastolysis following nephrogenic fibrosing dermopathy. J Am Acad Dermatol 53 (2005) 174-176
73. Ting W.W., Stone M.S., Madison K.C., and Kurtz K. Nephrogenic fibrosing dermopathy with systemic involvement. Arch Dermatol 139 (2003) 903-906
74. Swartz R.D., Crofford L.J., Phan S.H., Ike R.W., and Su L.D. Nephrogenic fibrosing dermopathy. A novel cutaneous fibrosing disorder in patients with renal failure. Am J Med 114 (2003) 563-572
75. Mackay-Wiggan J.M., Cohen D.J., Hardy M.A., Knobler E.H., and Grossman M.E. Nephrogenic fibrosing dermopathy (scleromyxedema-like illness of renal disease). J Am Acad Dermatol 48 (2003) 55-60
76. Grobner T. Gadolinium-a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?. Nephrol Dial Transplant 21 (2006) 1104-1108
77. Moreno-Romero J.A., Segura S., Mascaro J.M.Jr., Cowper S.E., Julia M., Poch E., Botey A., and Herrero C. Nephrogenic systemic fibrosis. A case series suggesting gadolinium as a aetiological factor. Br J Dermatol 157 (2007) 783-787
78. Cowper S.E., Su L.D., Bhawan J., Robin H.S., and LeBoit P.E. Nephrogenic fibrosing dermopathy. Am J Dermatopathol 23 (2001) 383-393
79. Kucher C., Xu X., Pasha T., and Elenitsas R. Histopathologic comparison of nephrogenic fibrosing dermopathy and scleromyxedema. J Cutan Pathol 32 (2005) 484-490
80. Schmook T., Budde K., Ulrich C., Neumayer H.H., Fritsche L., and Stockfleth E. Successful treatment of nephrogenic fibrosing dermopathy in a kidney transplant recipient with photodynamic therapy. Nephrol Dial Transplant 20 (2005) 220-222
81. Chung H.J., and Chung K.Y. Nephrogenic fibrosing dermopathy. response to high-dose intravenous immunoglobulin. Br J Dermatol 150 (2004) 596-597
82. Kafi R., Fisher G.J., Quan T., et al. UV-A1 phototherapy improves nephrogenic fibrosing dermopathy. Arch Dermatol 140 (2004) 1322-1324